| 产品编号 | bs-43077P |
| 英文名称 | Recombinant SARS-Cov-2 (Omicron, B.1.1.529) Spike trimer protein, C-His (HEK293) |
| 中文名称 | 重组SARS冠状病毒2奥密克戎变异株S-ECD三聚体蛋白 |
| 别 名 | SARS-CoV-2 spike protein; 2019-nCOV Spike protein; Spike glycoprotein; Spike protein S1; Surface glycoprotein; Spike protein RBD; SPIKE_SARS2; Recombinant SARS-Cov-2 (Omicron, B.1.1.529) Spike trimer protein, C-His (HEK293) |
| 理论分子量 | 137kDa |
| 检测分子量 | 150-180 |
| 性 状 | Lyophilized or Liquid |
| 浓 度 | ＞0.5 mg/ml |
| 物 种 | SARS-Cov-2 |
| 序 列 | 16-1213/1273 |
| 纯 度 | >90% as determined by SDS-PAGE |
| 纯化方法 | AC |
| 内毒素 | Not analyzed |
| 表达系统 | HEK293 cell |
| 活性 | Not tested |
| 标签 | C-His |
| 缓 冲 液 | PBS (pH7.4). |
| 保存条件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 产品介绍 |
The SARS-CoV-2 Spike protein (with mutations A67V, HV69-70del, T95I, G142D, VYY143-145del,N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K,G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, F817P, N856K, A892P, A899P, A942P, Q954H, N969K, L981F, K986P, V987P and R683A, R685A).The mutations were identified in the SARS-CoV-2 variant (known as Omicron/B.1.1.529) which emerged in the South Africa. SWISS: P0DTC2 Gene ID: 43740568 |
| 产品图片 |
The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
Measured by its binding ability in a indirect ELISA. Immobilized SARS-CoV-2 Spike trimer Protein (His Tag) (Omicron/B.1.1.529) (Cat: bs-43077P) at 2μg/mL (100 μL/Well) can bind Anti-SARS-CoV-2 Spike Monoclonal antibody (Cat:bsm-41622M&bsm-41476M&bsm-41630M).
Measured by its binding ability in a functional ELISA. Immobilized human ACE2, His-Avi Tag (Cat: bs-46001P) at 2μg/mL (100 μL/Well) can bind SARS-CoV-2 Spike trimer Protein (His Tag) (Omicron/B.1.1.529) (Cat: bs-43077P), the EC50 is 1.5μg/mL.
|
| 1、抗体溶解方法 | |
| 2、抗体修复方式 | |
| 3、常用试剂的配制 | |
| 4、免疫组化操作步骤 | |
| 5、免疫组化问题解答 | |
| 6、Western Blotting 操作步骤 | |
| 7、Western Blotting 问题解答 | |
| 8、关于肽链的设计 | |
| 9、多肽的溶解与保存 | |
| 10、酶标抗体效价测定程序 | |
